Company intelligence
ImmuneSpec
Excellence in immunopeptidomics for better, safer biotherapeutics.
About ImmuneSpec
ImmuneSpec is a next-generation immunopeptidomics platform that delivers unmatched precision in identifying peptides presented by MHC molecules. Powered by advanced mass spectrometry, ImmuneSpec provides deep, unbiased insight into immune presentation—enabling the development of safer, more effective biotherapeutics. The platform supports early detection of immunogenic regions in biologics, reducing immune risk and guiding safer drug design. ImmuneSpec also accelerates target discovery by revealing rare neoepitopes and validates constructs by confirming that designed epitopes are effectively presented. With rapid turnaround, high-throughput capability, and rigorous quality control, ImmuneSpec empowers researchers to advance transformative therapies—from personalized medicine to next-generation vaccines and immunotherapies.
Verified activity
Signals from ImmuneSpec
2 published signals
People
ImmuneSpec employee Elisa will help shape the scientific strategy, strengthen data analysis and bioinformatics approaches, support team development, and work directly with clients across immunology and translational projects.
Reported by ImmuneSpec
People
ImmuneSpec employee Elisa is a translational immunologist with expertise in T cell specificity, antigen-specific T and B cell analysis, TCR repertoire analysis, and bioinformatics.
Reported by ImmuneSpec